Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

NCT00828503 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Disease

Interventions

DRUG: Certican (everolimus) + valganciclovir
DRUG: Valganciclovir

Sponsor

Marcus Saemann